These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7363246)

  • 1. Specific immunoprophylaxis in experimental tumour-host systems.
    Prager MD; Gordon WC
    Can Med Assoc J; 1980 Apr; 122(7):780-4. PubMed ID: 7363246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agent.
    Prager MD; Gordon WC
    Cancer Res; 1978 Jul; 38(7):2052-7. PubMed ID: 657141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal cell populations during tumour injection.
    De Heer E; De Groot JW; Den Otter W; Dullens HF
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin-stimulated immune response to modified lymphoma cells.
    Prager MD; Ludden CM; Mandy WJ; Allison JP; Kitto GB
    J Natl Cancer Inst; 1975 Mar; 54(3):773-5. PubMed ID: 1168264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of antigens with dimethyldioctadecylammonium bromide, a chemically defined biological response modifier.
    Baechtel FS; Prager MD
    Cancer Res; 1982 Dec; 42(12):4959-63. PubMed ID: 7139599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
    Hanyecz A; Berlo SE; Szántó S; Broeren CP; Mikecz K; Glant TT
    Arthritis Rheum; 2004 May; 50(5):1665-76. PubMed ID: 15146438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro.
    Farram E; Festenstein H; de Giorgi L
    Clin Exp Immunol; 1978 Sep; 33(3):377-85. PubMed ID: 737892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethyl diotadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice.
    Snippe H; Belder M; Willers JM
    Immunology; 1977 Dec; 33(6):931-36. PubMed ID: 591002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice.
    Vangala A; Kirby D; Rosenkrands I; Agger EM; Andersen P; Perrie Y
    J Pharm Pharmacol; 2006 Jun; 58(6):787-99. PubMed ID: 16734980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.
    De Weger RA; Pels E; Den Otter W
    Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of macrophages in tumour immunity.
    Alexander P
    J Clin Pathol Suppl (R Coll Pathol); 1974; 7():77-82. PubMed ID: 4151535
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvanticity of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and Corynebacterium parvum with respect to host immune response to coccidial antigens.
    Lillehoj HS; Lindblad EB; Nichols M
    Avian Dis; 1993; 37(3):731-40. PubMed ID: 8257364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 17. Variable expression of delayed hypersensitivity in different mouse strains using dimethyl dioctadecyl ammonium bromide as an adjuvant.
    Snippe H; Johannesen L; Lizzio E; Merchant B
    Immunology; 1980 Mar; 39(3):399-405. PubMed ID: 7002767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant effect of quaternary ammonium compounds in a murine model.
    Larsen ST; Hansen R; Hammer M; Tegner U; Poulsen OM; Nielsen GD
    Toxicol Lett; 2004 Jul; 151(2):389-98. PubMed ID: 15183463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model.
    Maletzki C; Linnebacher M; Kreikemeyer B; Emmrich J
    Gut; 2008 Apr; 57(4):483-91. PubMed ID: 18025068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.
    Korsholm KS; Agger EM; Foged C; Christensen D; Dietrich J; Andersen CS; Geisler C; Andersen P
    Immunology; 2007 Jun; 121(2):216-26. PubMed ID: 17302734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.